Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Cited In for PubMed (Select 18204450)

1.

Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities.

Garcia V, Richter K, Graw F, Oxenius A, Regoes RR.

PLoS Comput Biol. 2015 May 1;11(5):e1004178. doi: 10.1371/journal.pcbi.1004178. eCollection 2015 May.

2.

Phage Display Engineered T Cell Receptors as Tools for the Study of Tumor Peptide-MHC Interactions.

Løset GÅ, Berntzen G, Frigstad T, Pollmann S, Gunnarsen KS, Sandlie I.

Front Oncol. 2015 Jan 12;4:378. doi: 10.3389/fonc.2014.00378. eCollection 2014. Review.

3.

Molecular mechanisms of CD8(+) T cell trafficking and localization.

Nolz JC.

Cell Mol Life Sci. 2015 Jul;72(13):2461-73. doi: 10.1007/s00018-015-1835-0. Epub 2015 Jan 11. Review.

PMID:
25577280
4.

Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.

Bergseng E, Dørum S, Arntzen MØ, Nielsen M, Nygård S, Buus S, de Souza GA, Sollid LM.

Immunogenetics. 2015 Feb;67(2):73-84. doi: 10.1007/s00251-014-0819-9. Epub 2014 Dec 12.

5.

Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.

Bergström SE, Uzunel M, Talme T, Bergdahl E, Sundqvist KG.

Immunology. 2015 Apr;144(4):687-703. doi: 10.1111/imm.12424.

PMID:
25393517
6.

BDC12-4.1 T-cell receptor transgenic insulin-specific CD4 T cells are resistant to in vitro differentiation into functional Foxp3+ T regulatory cells.

Sarikonda G, Fousteri G, Sachithanantham S, Miller JF, Dave A, Juntti T, Coppieters KT, von Herrath M.

PLoS One. 2014 Nov 13;9(11):e112242. doi: 10.1371/journal.pone.0112242. eCollection 2014.

7.

Spatial heterogeneity and peptide availability determine CTL killing efficiency in vivo.

Hogan T, Kadolsky U, Tung S, Seddon B, Yates A.

PLoS Comput Biol. 2014 Sep 18;10(9):e1003805. doi: 10.1371/journal.pcbi.1003805. eCollection 2014 Sep.

8.

Visualizing T Cell Migration in situ.

Benechet AP, Menon M, Khanna KM.

Front Immunol. 2014 Jul 29;5:363. doi: 10.3389/fimmu.2014.00363. eCollection 2014. Review.

9.

Random migration and signal integration promote rapid and robust T cell recruitment.

Textor J, Henrickson SE, Mandl JN, von Andrian UH, Westermann J, de Boer RJ, Beltman JB.

PLoS Comput Biol. 2014 Aug 7;10(8):e1003752. doi: 10.1371/journal.pcbi.1003752. eCollection 2014 Aug.

10.

Simulation of B cell affinity maturation explains enhanced antibody cross-reactivity induced by the polyvalent malaria vaccine AMA1.

Chaudhury S, Reifman J, Wallqvist A.

J Immunol. 2014 Sep 1;193(5):2073-86. doi: 10.4049/jimmunol.1401054. Epub 2014 Jul 30.

11.

Prolonged antigen presentation by immune complex-binding dendritic cells programs the proliferative capacity of memory CD8 T cells.

León B, Ballesteros-Tato A, Randall TD, Lund FE.

J Exp Med. 2014 Jul 28;211(8):1637-55. doi: 10.1084/jem.20131692. Epub 2014 Jul 7.

12.

T-cell-receptor-dependent signal intensity dominantly controls CD4(+) T cell polarization In Vivo.

van Panhuys N, Klauschen F, Germain RN.

Immunity. 2014 Jul 17;41(1):63-74. doi: 10.1016/j.immuni.2014.06.003. Epub 2014 Jun 26.

13.

A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs.

Kallen KJ, Theß A.

Ther Adv Vaccines. 2014 Jan;2(1):10-31. doi: 10.1177/2051013613508729. Review.

14.

Assessment of automated analyses of cell migration on flat and nanostructured surfaces.

Grădinaru C, Lopacińska JM, Huth J, Kestler HA, Flyvbjerg H, Mølhave K.

Comput Struct Biotechnol J. 2012 Nov 21;1:e201207004. doi: 10.5936/csbj.201207004. eCollection 2012.

15.

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity.

Dudek AM, Martin S, Garg AD, Agostinis P.

Front Immunol. 2013 Dec 11;4:438. doi: 10.3389/fimmu.2013.00438. Review.

16.

The N terminus of SKAP55 enables T cell adhesion to TCR and integrin ligands via distinct mechanisms.

Ophir MJ, Liu BC, Bunnell SC.

J Cell Biol. 2013 Dec 23;203(6):1021-41. doi: 10.1083/jcb.201305088.

17.

Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression.

Johnson MJ, Björkström NK, Petrovas C, Liang F, Gall JG, Loré K, Koup RA.

Vaccine. 2014 Feb 3;32(6):717-24. doi: 10.1016/j.vaccine.2013.11.055. Epub 2013 Dec 8.

18.

Natural regulatory T cells inhibit production of cytotoxic molecules in CD8⁺ T cells during low-level Friend retrovirus infection.

Zelinskyy G, Werner T, Dittmer U.

Retrovirology. 2013 Oct 24;10:109. doi: 10.1186/1742-4690-10-109.

19.

Regulation of T-cell receptor signaling by the actin cytoskeleton and poroelastic cytoplasm.

Beemiller P, Krummel MF.

Immunol Rev. 2013 Nov;256(1):148-59. doi: 10.1111/imr.12120. Review.

20.

Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy.

Jaini R, Rayman P, Cohen PA, Finke JH, Tuohy VK.

Int J Cancer. 2014 Apr 1;134(7):1695-705. doi: 10.1002/ijc.28488. Epub 2013 Oct 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk